Divi's Laboratories Limited vs Kimia Biosciences Ltd

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and Kimia Biosciences Ltd (KIMIABIOSCIENCESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs KIMIABIOSCIENCESLTD on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth10
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.52
P/E ratio
19.40
14.90
P/B ratio
7.88
0.32%
Dividend yield
0.00%
₹96.75
EPS
₹2.03

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
53.70%
20.35%
Return on capital
42.00%
32.59%
EBITDA margin
17.00%
24.32%
Net margin
8.40%

Growth

DIVISLAB takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
-3.79%
12.09%
Profit CAGR (3Y) even
—

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹135 Cr
₹10,560 Cr
Revenue
₹119 Cr
₹2,568 Cr
Net profit
₹10 Cr
0.00
Debt / equity
1.94
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Kimia Biosciences Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 53.6%"]
  • − ["Stock is trading at 7.37 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of -2.84% over past five years.", "Tax rate seems low"]
Divi's Laboratories Limited full analysis Kimia Biosciences Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs KIMIABIOSCIENCESLTD: Share Price, Valuation & Which to Buy | DocStoX